Bleeding. Other specified disorders of nose and nasal sinuses
Conditions
Interventions
Intervention 1: Intervention 1) 900 mg (3×300 mg capsules) Gabapentin made by Iran Darou industries is taken single daily dose with 20 ml water, 2 hours before operation. Intervention 2: Intervention
Treatment - Drugs
Intervention 1) 900 mg (3×300 mg capsules) Gabapentin made by Iran Darou industries is taken single daily dose with 20 ml water, 2 hours before operation
Intervention 2) Three capsules looking exactly like Gabapentin capsule including placebo which is made by the same industry is taken by the patient 2 hours before surgery
Sponsors
Vice Chancellor for research of Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 18 to 45 years old; American Society of Anesthesiologists (ASA) I,II; Candidate for Septorinoplasty Exclusion criteria: Drug Side effects; Patients refuse treatment
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart Rate. Timepoint: Upon arrival to operating room,3 ,5 ,10 ,15 minutes after endotracheal intubatioin and 10 minutes after extubation. Method of measurement: Beats per minute (bpm) by Saadat monitoring system.;Systolic Blood Pressure. Timepoint: Upon arrival to operating room,3 ,5 ,10 ,15 minutes after endotracheal intubatioin and 10 minutes after extubation. Method of measurement: mmHg by Saadat monitoring system.;Amount of intra operative bleeding. Timepoint: At the end of the operation. Method of measurement: mL/According to the blood volume in the suction, by minus volume of physiological saline solution that added due to washing , plus 15 for each blood gaus. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnoush Farzi
Guilan University of Medical Sciences
Outcome results
None listed